Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis

INTRODUCTION: A large-scale clinical trial, the Sequence Trial Alternatives to Relieve Depression (STAR*D) study, concluded that about one-third of the studied patients with major depressive disorder remitted during the initial treatment with selective serotonin reuptake inhibitors and that approxim...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Masayoshi, Murata, Yusuke, Matsuo, Asami, Takemoto, Tomoyo, Mine, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381917/
https://www.ncbi.nlm.nih.gov/pubmed/26000223
http://dx.doi.org/10.1007/s40120-013-0015-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381917/
https://www.ncbi.nlm.nih.gov/pubmed/26000223
http://dx.doi.org/10.1007/s40120-013-0015-0

Ejemplares similares